Shinya Tokuhiro

3.2k total citations
21 papers, 1.3k citations indexed

About

Shinya Tokuhiro is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Shinya Tokuhiro has authored 21 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Oncology. Recurrent topics in Shinya Tokuhiro's work include Alzheimer's disease research and treatments (8 papers), Drug Transport and Resistance Mechanisms (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Shinya Tokuhiro is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Drug Transport and Resistance Mechanisms (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Shinya Tokuhiro collaborates with scholars based in Japan, United States and Germany. Shinya Tokuhiro's co-authors include Takeshi Iwatsubo, Takaomi C. Saido, Kei Maruyama, Taisuke Tomita, Ryo Yamada, Kazuhiko Yamamoto, Kazuo Shinozaki, Jochen Walter, Akari Suzuki and Anja Capell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Shinya Tokuhiro

21 papers receiving 1.3k citations

Peers

Shinya Tokuhiro
Luc Mercken France
Deborah L. Mortensen United States
Chantal Bazenet United Kingdom
Leonard P. Adam United States
Andrea Rittger Germany
Anne Châteauneuf Canada
Amee J. George Australia
Ryuichi Tozawa Japan
Matthew L. Hemming United States
Krzysztof Paliga Germany
Luc Mercken France
Shinya Tokuhiro
Citations per year, relative to Shinya Tokuhiro Shinya Tokuhiro (= 1×) peers Luc Mercken

Countries citing papers authored by Shinya Tokuhiro

Since Specialization
Citations

This map shows the geographic impact of Shinya Tokuhiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinya Tokuhiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinya Tokuhiro more than expected).

Fields of papers citing papers by Shinya Tokuhiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinya Tokuhiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinya Tokuhiro. The network helps show where Shinya Tokuhiro may publish in the future.

Co-authorship network of co-authors of Shinya Tokuhiro

This figure shows the co-authorship network connecting the top 25 collaborators of Shinya Tokuhiro. A scholar is included among the top collaborators of Shinya Tokuhiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinya Tokuhiro. Shinya Tokuhiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yasuda, Satoru, Yusuke Yokouchi, Ken Sakurai, et al.. (2018). Preclinical efficacy studies of DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd.. Journal of Clinical Oncology. 36(15_suppl). e24206–e24206. 14 indexed citations
3.
Ciprotti, Marika, Reimar Abraham, Mendel Jansen, et al.. (2016). A phase I, open label, two part, safety and tolerability study of U3-1784 in patients with advanced solid tumours.. Journal of Clinical Oncology. 34(15_suppl). TPS2593–TPS2593. 2 indexed citations
4.
Sinha, Namita, David A. Grimes, Shinya Tokuhiro, et al.. (2013). Variant Alzheimer's Disease with Spastic Paraparesis and Supranuclear Gaze Palsy. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(2). 249–251. 1 indexed citations
5.
Tokuhiro, Shinya, Akira Shinagawa, Joseph R. Walker, et al.. (2012). Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure. Journal of Human Genetics. 57(8). 531–544. 6 indexed citations
6.
Reitz, Christiane, Shinya Tokuhiro, Lorraine N. Clark, et al.. (2010). SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Annals of Neurology. 69(1). 47–64. 96 indexed citations
7.
Robertson, Janice, J. M. Bilbao, Lorne Zinman, et al.. (2010). A novel double mutation in FUS gene causing sporadic ALS. Neurobiology of Aging. 32(3). 553.e27–553.e30. 33 indexed citations
8.
Reitz, Christiane, Shinya Tokuhiro, Lorraine N. Clark, et al.. (2010). P4‐031: Sorcs1 Alters APP Processing and Variants may Increase Alzheimer's Disease Risk. Alzheimer s & Dementia. 6(4S_Part_20). 3 indexed citations
9.
Tokuhiro, Shinya, et al.. (2007). Fine-Tuning of ENA ® Gapmers as Antisense Oligonucleotides for Sequence-Specific Inhibition. Oligonucleotides. 17(3). 291–301. 3 indexed citations
10.
Tokuhiro, Shinya, et al.. (2006). Design of ENA® gapmers as fine-tuning antisense oligonucleotides with sequence-specific inhibitory activity on mouse PADI4 mRNA expression. Nucleic Acids Symposium Series. 50(1). 319–320. 2 indexed citations
11.
Kawaida, Reimi, Ryo Yamada, Ken Kobayashi, et al.. (2005). CUL1, a component of E3 ubiquitin ligase, alters lymphocyte signal transduction with possible effect on rheumatoid arthritis. Genes and Immunity. 6(3). 194–202. 27 indexed citations
12.
Yamada, Ryo, et al.. (2004). SLC22A4 and RUNX1: identification of RA susceptible genes. Journal of Molecular Medicine. 82(9). 558–64. 22 indexed citations
13.
Tokuhiro, Shinya, et al.. (2003). β-Amyloid-specific upregulation of stearoyl coenzyme A desaturase-1 in macrophages. Biochemical and Biophysical Research Communications. 303(1). 302–305. 19 indexed citations
14.
Tokuhiro, Shinya, Ryo Yamada, Xiaotian Chang, et al.. (2003). An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nature Genetics. 35(4). 341–348. 488 indexed citations
15.
Yamamoto, Kazuhiko, Akari Suzuki, Xiaotian Chang, et al.. (2003). Functional haplotypes in citrullinating enzyme peptidylarginine deiminase 4 are associated with rheumatoid arthritis. Arthritis Research. 5(Suppl 3). 75–75. 1 indexed citations
16.
Tokuhiro, Shinya, et al.. (2002). A novel compound, RS-1178, specifically inhibits neuronal cell death mediated by β-amyloid-induced macrophage activation in vitro. Brain Research. 946(2). 298–306. 21 indexed citations
17.
Wang, Guanghui, Kenichi Mitsui, Svetlana Kotliarova, et al.. (1999). Caspase activation during apoptotic cell death induced by expanded polyglutamine in N2a cells. Neuroreport. 10(12). 2435–2438. 82 indexed citations
18.
Tomita, Taisuke, Shinya Tokuhiro, Tadafumi Hashimoto, et al.. (1998). Molecular Dissection of Domains in Mutant Presenilin 2 That Mediate Overproduction of Amyloidogenic Forms of Amyloid β Peptides. Journal of Biological Chemistry. 273(33). 21153–21160. 68 indexed citations
19.
Tokuhiro, Shinya, Taisuke Tomita, Hiroshi Iwata, et al.. (1998). The Presenilin 1 Mutation (M146V) Linked to Familial Alzheimer's Disease Attenuates the Neuronal Differentiation of NTera 2 Cells. Biochemical and Biophysical Research Communications. 244(3). 751–755. 13 indexed citations
20.
Morimoto, Yosuke, et al.. (1995). Protective Effects of Some Neutral Amino Acids against Hypotonic Hemolysis.. Biological and Pharmaceutical Bulletin. 18(10). 1417–1422. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luc Mercken Breakdown of academic impact, for papers by Deborah L. Mortensen Breakdown of academic impact, for papers by Chantal Bazenet Breakdown of academic impact, for papers by Leonard P. Adam Breakdown of academic impact, for papers by Andrea Rittger Breakdown of academic impact, for papers by Anne Châteauneuf Breakdown of academic impact, for papers by Amee J. George Breakdown of academic impact, for papers by Ryuichi Tozawa Breakdown of academic impact, for papers by Matthew L. Hemming Breakdown of academic impact, for papers by Krzysztof Paliga
Rankless by CCL
2026